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Abstract
Background: Peri-infarct border zone (BZ) as quantified by late gadolinium enhancement
(LGE) on cardiac magnetic resonance imaging (MRI) has been proposed as a risk stratification
tool, and is associated with increased mortality. BZ has been measured by various methods in
the literature. We assessed which BZ analysis best predicts inducible arrhythmia during
electrophysiological study (EPS).
Methods: LGE was performed in 47 patients with coronary artery disease referred for EPS to
assess for ventricular tachycardia (VT). LGE data was analyzed for BZ quantification by
3 previously published methods. Method I (BZ-I) used pixels 2–3 standard deviations over the
mean of normal tissue, expressed as % of left ventricular mass, Method II (BZ-II, as described
by Yan) and Method III (BZ-III, as described by Schmidt). EPS results were classified as
negative (non-inducible) or positive (monomorphic VT — MVT).
Results: There were 47 subjects-age 61.7 years, 72% male. During EPS, 20 patients were
non-inducible and 18 had induced MVT. Ejection fraction was not significantly different
between non-inducible patients and those with MVT (34.1% vs. 28.5%, p = 0.13). BZ-I was
significantly different (1.4% vs. 2.6%, p = 0.001), but not BZ-II (7.9% vs. 6.9%, p = 0.68) or
BZ-III (2.7 g vs. 2.1 g, p = 0.88). Multivariate analysis demonstrated that only BZ-I was an
independent predictor of EPS outcome after controling for infarct size (OR 1.97 per % change,
95% CI 1.04–3.73, p = 0.04).
Conclusions: This study demonstrates significant variability between the published methods
for measuring BZ. Also, BZ-I is a stronger predictor of inducible MVT during EPS than
ejection fraction and infarct size. BZ may be another LGE marker of elevated risk of
arrhythmia. (Cardiol J 2013; 20, 1: 68–77)
Key words: cardiac magnetic resonance imaging, ventricular tachycardia,
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Introduction
Sudden cardiac death (SCD) remains a perva-
sive modern health concern, with over 300,000
deaths annually in the United States alone [1]. Im-
plantable defibrillators have proven to be an effec-
tive treatment modality in selected patients with
coronary artery disease (CAD) [2–5]. The most
widely used risk identifier for determining patients
at risk for SCD is left ventricular ejection fraction
(LVEF) [6]. While an effective parameter, LVEF has
limited sensitivity and specificity; therefore iden-
tifying individuals at risk of SCD after myocardial
infarction (MI) continues to be a challenging prob-
lem [7, 8]. SCD in patients with CAD is predomi-
nantly caused by ventricular tachycardia (VT) or
ventricular fibrillation (VF) [4, 9]. The anatomic
substrate defined by the infarction is a main com-
ponent in the pathogenesis of these arrhythmias.
Given cardiac magnetic resonance imaging’s (MRI)
ability to delineate the infarction [10], infarct char-
acterization by cardiac MRI (CMR) has become an
evolving novel method for risk stratification [11–14].
Infarct size is a known determinant of the risk
for occurrence of VT [15–17]. Recent human stud-
ies have demonstrated that infarct characterization
by late gadolinium enhancement (LGE) on CMR is
predictive of overall mortality [12] as well as induc-
ibility of ventricular arrhythmia during electrophys-
iological study (EPS) [11, 18]. The peri-infarct bor-
der zone (BZ) has been defined histologically as the
area of viable myocardium immediately adjacent to
infarcted myocardium. This region has previously
been shown in animal models to identify areas of
abnormal enzyme activity, as well as altered elec-
trical activation properties [19, 20]. Recently, “grey
zone” imaging, has been introduced as a method for
identifying the BZ by LGE and has been associated
with increased mortality in a human population [14].
In delayed-enhanced CMR images, normal myocar-
dium appears black and infarct white. The authors
postulated that pixels with intermediate (grey) in-
tensity identify a potentially arrhythmic heteroge-
neous zone of viable and nonviable peri-infarct my-
ocardium, but this has not been confirmed patho-
logically. If this indeed represents the substrate for
reentrant ventricular arrhythmias, there should be
increased BZ among patients with inducible mono-
morphic VT (MVT) at EPS, a well accepted modal-
ity to demonstrate this substrate [21, 22]. Schmidt
et al. [18] did identify BZ (in grams) to be a predic-
tor of inducible VT, but infarct size was not. Inter-
estingly, the techniques used for BZ quantitation
in these latter 2 studies differed [14, 18]. Based on
these recent data, we evaluated the predictive va-
lue of BZ relative to infarct size in our previously
reported study of CMR determined infarct size and
its relationship to inducible VT [11]. We hypothe-
sized that BZ quantification by LGE would be more
predictive of inducible arrhythmia during EPS than
infarct size and ejection fraction.
Methods
This study was approved by the Northwestern
University Institutional Review Board. This was
a retrospective reanalysis of data from a prior study
[11], in which 48 patients, all with known history of
either chronic CAD or distant MI, were referred for
EPS to assess for inducibility of VT for primary pre-
vention risk stratification of sudden death. No pa-
tients had prior history of sustained ventricular ar-
rhythmias.
In this study, these LGE data were re-analyzed
for BZ quantification. One patient’s CMR could not
be recovered and was excluded from this analysis.
Patients underwent CMR within 32 ± 6 days of
EPS, per the protocol of the prior study [11]. Pa-
tients were placed supine in a 1.5-T Magnetom
Sonata scanner (Siemens, Medical Solutions, Mal-
vern, Pennsylvania); fiberoptic electrocardiographic
(ECG) leads were placed for scanner gating and
a phased-array receiver coil was placed on the chest
for imaging. All images were acquired using 10- to
15-s breath-holds. Short-axis cines were acquired
from the base to apex, making sure to include the
entire left ventricle (LV) using methods previous-
ly described [23, 24]. Typical CMR parameters
were: matrix resolution 256, field-of-view 340–
–400 mm × 225–380 mm, slice thickness 6 mm,
voxel size 1.33–1.56 mm × 1.56–2.43 mm × 6 mm.
No parallel imaging was used. Repetition time (typi-
cally 59–60 ms) was selected to be 100 ms less than
the R-R interval, to place the acquisition window
within end-diastole, with 23–25 segments per car-
diac cycle. Delayed-enhanced images were obtained
more than 10 min following intravenous admi-
nistration of a gadolinium-based contrast agent
(0.2 mmol/kg, Magnevist, Berlex Pharmaceuticals,
Wayne, New Jersey) using a T1-weighted, inver-
sion-recovery, segmented fast gradient-echo pulse
sequence [25]. The inversion time was adjusted
throughout the scan to null normal myocardium.
The methods used for the quantification of LVEF,
infarct size, and infarct surface area have all been
previously described [11]. Briefly, endocardial and
epicardial borders of the myocardium were manu-
ally planimetered on the short-axis cine images for
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each patient. Volumes were derived by summation
of the pixel areas, followed by multiplication of in-
plane resolution and the effective slice thickness.
The LVEF was computed as (end-diastolic volume
– end-systolic volume)/end-diastolic volume. LV
mass was determined by subtracting endocardial
volume from epicardial volume at end-diastole and
multiplying by a density of 1.05 g/mL [18]. Infarct
morphology was evaluated using the ceMRI imag-
es. The presence of MI, its location, and the degree
of transmurality were agreed upon by two observ-
ers. To measure infarct mass and surface area, the
infarct region was outlined according to whether the
image intensity was ≥ 2 SD that of a remote region
in the same slice. From the contours, a pixel value
was computed for the area and surface of each indi-
vidual infarct territory. Based on the pixel values, the
image resolution and slice thickness, and an assumed
density of 1.05 g/mL, the pixel values were convert-
ed into actual cardiac masses and surface areas.
Electrophysiologic study was performed using
standard techniques. Programmed ventricular
stimulation was performed using up to three ex-
trastimuli at two right ventricular sites during
2 drive-cycle lengths. Study end points were either
induction of sustained VT or completion of the
study protocol. EPS results had been previously
classified as negative (no inducible ventricular ta-
chyarrhythmia) (n = 20), inducible MVT (n = 18),
or inducible VF or polymorphic VT (PVT) (n = 9).
Because inducible PVT/VF is considered a non-
specific result during EPS, the primary analysis
comparing LGE results, as well as comparing the
different BZ calculation methods, evaluates the
non-inducible group vs. those with inducible MVT,
as in the original report. However, baseline char-
acteristics and long-term outcomes are reported
for all subjects.
Border zone has been previously quantified
using two statistical techniques. Yan et al. [14] de-
fined BZ by regions of signal intensity between
2 and 3 SD above normal myocardium. They then
indexed this measure to the infarct size. Of note,
using this index, there was an inverse relationship
between infarct size and BZ (i.e. the larger the in-
farct, the smaller the BZ). Schmidt et al. [18] defined
all pixels with signal intensity above the peak in-
tensity in an area of normal myocardium and below
50% of the peak intensity in the infarcted region as
BZ. As neither definition has pathologic correlation,
we analyzed the current data using both definitions.
In addition, when LGE BZ was measured with the
first method, we also indexed this to the total LV
mass. As will be demonstrated, this restores the
expected positive geometric relationship between
infarct size and BZ (i.e. the larger the infarct, the
larger the BZ).
All image analysis was performed by a single
investigator, blinded to the results of prior analy-
sis, clinical outcomes and to EPS results. The meth-
ods for image analysis have been described in de-
tail [26]. Briefly, all short-axis delayed-enhance-
ment images from apex to base were reviewed
offline using ImageJ (National Institute of Mental
Health). A custom macro for ImageJ was written for
the semi-automated quantification of LGE BZ. The
macro-analyzes a single, post-contrast short axis
image. The user first defines a region of LV remote
from the infarct that appears normal. Next, epicar-
dial and endocardial surfaces are defined. The macro
generates a summation of all LV pixels that meet
criteria for normal, BZ, or core infarct.
Due to significant variations in the published
methods by which to calculate BZ, we next per-
formed the BZ analysis by 3 different methods,
which will be referred to as BZ-I, BZ-II, and BZ-III.
Border zone-I was defined as all pixels in the en-
docardium that were between 2 and 3 SD above the
mean of the normal region, and core infarct those
above 3. Border zone and core infarct were report-
ed as a percentage of the total LV mass. Border
zone-II was defined as in method I, but the values
of BZ were reported as a percent of infarct size as
described by Yan et al. [14] In BZ-III, BZ and core
infarct mass were calculated using the full-width
half-maximum method as described by Schmidt et
al. [18]. For all methods, pixels between 2 and 3 SD
above the mean of the remote region that were not
adjacent to areas of core infarction (> 3 SD above
remote mean) were not included in the BZ calcula-
tion. Two example studies are shown in Figure 1,
comparing all 3 methods of BZ calculation.
Follow-up data on implantable cardioverter-
-defibrillator (ICD) shocks and mortality were as-
sessed for all 47 patients by referencing the social
security death index, as well as hospital and ICD
chart review. ICD programming was done at the
discretion of the treating physician; the average VT
or VF zone cut-off was 167 bpm, range 95–188. Ap-
propriate therapy was considered any high-energy
shock or anti-tachycardia pacing for sustained ven-
tricular arrhythmia.
Statistical analysis
Results are expressed as mean ± SD, unless
otherwise noted. Discrete variables were compared
across patient groups using the c2, Fisher, or Spear-
man tests where appropriate. Continuous variables
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were compared with Student’s t-test, Kruskal-Wal-
lis or Mann-Whitney tests, where appropriate. Ana-
lysis of non-parametric parameters (EF, infarct size,
infarct surface area, LV mass, and BZ) utilize the
Kruskal-Wallis test, and are reported as median
value (1st quartile, 3rd quartile). Analysis of variance
was performed to compare characteristics among
all 3 EPS groups. Two separate multivariate logis-
tical regressions were performed to identify inde-
pendent determinants of EPS outcome for each
method; one using BZ and infarct mass percentage
alone, and one using BZ, infarct mass percentage
and LVEF. A 2-tailed p-value < 0.05 was consid-
ered statistically significant. All analysis was per-
formed using SPSS 16.0 (SPSS Inc, Chicago, IL).
The authors had full access to the data and take re-
sponsibility for its integrity. All authors have read
and agree to the manuscript as written.
Results
The study group consisted of 47 subjects with
an average age of 61.7 ± 11.4 years and 72% were
male. During EPS, 20 patients had no inducible
ventricular arrhythmias, 9 had PVT or VF, and
18 had induced MVT. Baseline characteristics are
shown in Table 1. There were no significant dif-
ferences among the three groups in terms of his-
tory of MI, congestive heart failure, diabetes mel-
litus, or beta-blocker and ACE inhibitor use. Only
age, gender, and a reported history of hyperten-
sion were significantly different between the
3 EPS outcome groups. QRS duration on baseline
12-lead ECG was 110 ± 6 ms in the non-inducible
group, 121 ± 5 ms in the MVT group, and 118 ±
± 11 ms in the VF group, which was a non-signi-
ficant difference.
CMR results
The differences in LGE results between the
non-inducible and inducible EPS groups are shown
in Table 2. As previously reported, LVEF was not
significantly different between non-inducible patients
and those with MVT (34.1% vs. 28.5%, p = 0.13),
while infarct size (15.8% vs. 23.1%, p = 0.03) and
surface area (104.4 cm2 vs. 169.8 cm2, p = 0.002) were.
No areas of microvascular obstruction were noted.
All patients except 3 had some evidence of LGE
(2 in non-inducible group, 1 in VF group). Analysis
was repeated excluding these 3 patients, but no
results were significantly altered. All results shown




Figure 1. Example late gadolinium enhancement (LGE) images contrasting border zone (BZ) methods. Row 1 is
a patient with a BZ of 2.5% by BZ-I, 11.2% by BZ-II, and 1.33 g (1.1% of left ventricular mass [LVM]) by BZ-III. This
patient had an infarct size of 14.4%, ejection fraction of 36.1%, and was inducible for monomorphic ventricular
tachycardia during electrophysiology study (EPS). Row 2 is a patient with a BZ of 0.8% by BZ-I, 4.1% by BZ-II, and
7.47 g (7.3% of LVM) by BZ-III. This patient had an infarct size of 15.4%, ejection fraction of 18.3%, and was non-
inducible during EPS. Column A shows the original magnetic resonance image with the endocardial, epicardial and
normal region of interest identified in white. Column B demonstrates core infarct in red and BZ in yellow, as
determined by BZ-I and BZ-II. Column C demonstrates core infarct in red and BZ in yellow, as determined by BZ-III.
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All 47 patients had BZ analysis performed by
all 3 methods. Table 2 shows a comparison of BZ
quantification as described in this study (BZ-I), in
Yan et al. [14] (BZ-II), and in Schmidt et al. [18]
(BZ-III). Border zone was significantly different be-
tween the non-inducible and MVT EPS groups using
BZ-I (1.4% vs. 2.6%, p = 0.001), but not using BZ-II
(7.9% vs. 6.9%, p = 0.68) or BZ-III (2.7 g vs. 2.1 g,
p = 0.88). The relationship of BZ by each method
to infarct size is demonstrated in Figure 3.
Several multivariate logistical regression models
were evaluated, as shown in Table 3. The first mo-
del included both infarct size and BZ-I (model 1),
which demonstrated that BZ-I was the only signif-
icant predictor (OR 1.84 per % change, 95% CI
1.03–3.28, p = 0.04). When including LVEF, infarct
size and BZ-I (model 2), BZ-I was again the only
independent predictor of EPS outcome (OR 2.07 per
% change, 95% CI 1.08–3.98, p = 0.03). In a sepa-
rate model that included BZ-I and infarct surface
area (model 3), the confidence intervals for the OR
for BZ-I (OR 1.71, 95% CI 0.98–3.01, p = 0.06) in-
cluded 1, but is still consistent with the value of this
parameter as a predictor of EPS outcome.
Another multivariate logistical regression mod-
el that included infarct size and BZ-II demonstrat-
ed that BZ-II was not a predictor of EPS outcome
(OR 0.95 per % change, 95% CI 0.85–1.07, p =
= 0.395). When including both infarct size and LVEF
in the model, BZ-II was still not a predictor (OR 0.95
per % change, 95% CI 0.85–1.06, p = 0.378). In
model 4, which included BZ-I, BZ-II and BZ-III, only
BZ-I was a significant, independent predictor of EPS
outcome (OR 2.74 per % change, 95% CI 1.34–5.58,
p = 0.006).
Another logistical regression model was per-
formed that included LVEF, infarct size and BZ-III.
This analysis demonstrated that only infarct size
was an independent predictors of EPS outcome, and
BZ-III was not (OR 0.93 per % change, 95% CI
0.78–1.11, p = 0.41). In a model that included only
BZ-III and infarct size, BZ-III again was not a signi-
ficant predictor (OR 0.92 per % change, 95% CI
0.77–1.10, p = 0.35).
Table 1. Baseline characteristics
Total Non-inducible PVT/VF MVT
(n = 47) (n = 20) (n = 9) (n = 18)
Male 26 10 8 16
Age 61.7 ± 11.4 59.3 ± 11.9 71.4 ± 10.6 61.3 ± 9.7
History of MI 25 12 4 13
History of CHF 26 12 4 14
History of HTN 19 8 1 11
History of DM 11 6 0 5
History of HL 20 7 4 13
Beta-blocker 30 16 8 14
ACE-I 32 15 6 17
PVT — polymorphic ventricular tachycardia; VF — ventrifcular fibrillation; MVT — monomorphic ventricular tachycardia; MI — myocardial infarction;
CHF — congestive heart failure; HTN — hypertension; DM — diabetes mellitus; HL — hyperlipidemia; ACE-I — angiotensin converting enzyme inhibitor
Table 2. Magnetic resonance imaging characteristics.
Total Non-inducible MVT P
(n = 38) (n = 20) (n = 18)
LVEF [%] 32.21 (22.5, 33.9) 34.09 (22.7, 44.4) 28.48 (21.9, 36.0) 0.13
Infarct size [%] 18.49 (13.5, 34.1) 15.84 (6.6, 23.4) 23.07 (15.5, 35.25) 0.026
Infarct SA [cm2] 115.97 (94.8, 181.75) 104.37 (63.5, 145.6) 169.84 (116.4, 227.5) 0.002
LV mass [g] 195.36 (147.6, 234.2) 195.4 (143.6, 231.1) 193.5 (153.3, 236.3) 0.953
Border zone-I [%] 2.10 (1.3, 3.7) 1.35 (0.4, 2.2) 2.64 (2.1, 4.3) 0.001
Border zone-II [%] 7.13 (5.0, 11.7) 7.88 (4.8, 15.2) 6.89 (5.0, 10.1) 0.68
Border zone-III [g] 2.09 (0.5, 7.4) 2.69 (0.3, 7.4) 2.09 (0.6, 7.5) 0.883
Values as median (1st quatile, 3rd quartile); MVT — monomorphic ventricular tachycardia; LVEF — left ventricular ejection fraction; SA — surface area;
LV — left ventricular
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In order to examine if BZ had a simply largely
geometric relation to infarct size and surface area
or was a unique measurement, its correlation with
other infarct characteristics was evaluated. As
shown in Figure 2, the original measurements of
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Figure 2. Infarct size (%left ventricular mass) vs. infarct
surface area [cm2].
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Table 3. Univariate and selected mutivariate ana-
lyses.
LGE variable OR (95% CI) P
Univariate
Age 1.04 (0.98–1.12) 0.216
History of CHF 0.43 (0.09–1.95) 0.274
Gender 0.11 (0.02–0.65) 0.015
Infarct size 1.07 (1.01–1.14) 0.026
Border zone-I 2.10 (1.21–3.65) 0.008
Border zone-II 0.95 (0.85–1.05) 0.310
Border zone-III 0.97 (0.83–1.14) 0.748
LVEF 0.95 (0.89–1.01) 0.095
Multivariate
Model 1
Border zone-I 1.84 (1.03–3.28) 0.040
Infarct size 1.04 (0.97–1.11) 0.270
Model 2
Border zone-I 2.07 (1.08–3.98) 0.029
Infarct size 1.01 (0.94–1.09) 0.749
LVEF 0.94(0.86–1.02) 0.158
Model 3
Border zone-I 1.71 (0.98–3.01) 0.061
Surface area 1.00 (1.00–1.00) 0.076
Model 4
Border zone-I 2.74 (1.34–5.58) 0.006
Border zone-II 0.82 (0.65–1.04) 0.098
Border zone-III 0.88 (0.72–1.08) 0.216
Model 5
Gender 0.16 (0.02–1.09) 0.061
Border zone-I 1.63 (0.93–2.84) 0.087
OR — odds ratio; CI — confidence interval; CHF — congestive heart
failure; LVEF — left ventricular ejection fraction
Figure 3. Comparison of infarct size vs. the three diffe-
rent methods of borderzone quantification. From the
top to the botton: Border zone as a percent of left ventri-
cular mass mass (border zone-I), Border zone as a per-
cent of infarct size (border zone-II), and border zone
mass by full-width half-max method (border zone-III).
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infarct size and surface area were highly correlated
(R2 = 0.587, p < 0.001). However, as demonstrated
in Figure 3, the correlation of BZ-I (R2 = 0.24,
p = 0.002), BZ-II (R2 = 0.02, p = 0.43), and BZ-III
(R2 = 0.05, p = 0.16) to infarct size was poor. The
correlation of BZ-I (R2 = 0.19, p = 0.007), BZ-II
(R2 = 0.06, p = 0.13), and BZ-III (R2 = 0.08, p = 0.08)
to infarct surface area was also poor. The correla-
tion among the different BZ measurements was also
poor (BZ-I vs. BZ-II: R2 = 0.02, p = 0.44; BZ-I vs.
BZ-III: R2 = 0.003, p = 0.77; BZ-II vs. BZ-III: R2 =
= 0.083, p = 0.08).
Long-term outcomes
While not powered for outcome data, long-term
data were available for the original study partici-
pants. Average follow-up was 1383.8 ± 617.0 days.
There were 14 deaths, 6 in the non-inducible group
(30.0%), 2 in the PVT and VF group (22.2%), and
6 in the MVT group (33.3%). There was no signifi-
cant difference in mortality among the groups.
Cause of death was not known for all patients. There
were 26 ICD implants (4 in the non-inducible group,
5 in the PVT/VF group and 17 in the MVT group).
Five patients received appropriate ICD therapy for
spontaneous ventricular arrhythmias (1 in the non-
inducible group, 4 in the MVT group).
Border zone was not significantly different be-
tween patients alive vs. dead by any method; BZ-I
(1.9% vs. 2.4, p = 0.6), BZ-II (6.9% vs. 9.4%, p = 0.3)
or BZ-III (2.3 g vs. 1.4 g, p = 0.6). When age was
controlled for, neither EPS outcome nor BZ was
predictive of death or a composite endpoint of death
or appropriate ICD therapy.
Discussion
The principle finding of this study is that BZ
quantified by three different techniques on the same
set of CMRs provides dramatically different results.
The measurements of BZ-I, BZ-II, and BZ-III are
not highly correlated with each other and the rela-
tionship with total infarct mass markedly differs so
that BZ-II is inversely related to infarct mass while
BZ-I and BZ-III are directly related. Furthermore,
while BZ-I is an independent predictor of induction
of MVT during EPS in this patient cohort, neither
BZ-II nor BZ-III were. Further studies will be re-
quired to determine which of these measurements
provides the most realistic physiologic measure-
ment of the BZ, and which provides optimal prog-
nostic information.
Ventricular tachycardia commonly arises from
reentry around a fixed lesion, such as an infarct scar
[21, 27]. The critical region for these VT has been
shown histologically to be bundles of surviving
myocytes in the immediate peri-infarct area — the
border zone [21]. Intracardiac electrical mapping
studies have confirmed that the peri-infarct area is
typically involved in VT [28–31], and catheter-based
mapping and ablation of these areas has been shown
to be an effective therapy for VT [32]. Slow con-
duction, a required component of reentrant arrhyth-
mias, is found in the border of healing infarcts [33,
34]. In addition, areas of patchy infarct that may pro-
vide the geometric substrate for reentry [15], as
well as areas of mixed dead and viable myocardium
[21] have all been identified in the peri-infarct zone.
There are various clinical tests to attempt to
identify patients with this substrate for ventricular
arrhythmias. Some tests identify anatomic features
associated with the peri-infarct border zone — for
example, infarct size might be expected to be re-
lated to the mass of BZ present. As infarct size, until
recently, could not be accurately measured, LVEF
has been used as a surrogate risk marker. Although
many factors influence LVEF [35, 36], in general,
larger infarcts are associated with lower LVEF. As
this has been a readily clinically available tool, it has
been extensively studied and shown to be a useful
predictor of SCD [37, 38]. LGE measurement of
infarct scar by delayed-enhancement with gadolin-
ium is a more specific measure of infarct size, al-
lowing for direct quantification of the infarct mor-
phology, which may be linked to arrythmogenesis
[11]. EPS is a non-anatomic risk stratification tool
that examines the electrical properties of the ven-
tricle and identifies the presence of substrate for
VT. BZ measurement, however, has the potential
to be a direct, non-invasive measure of the anatomic
substrate which has previously been only histolo-
gically defined.
While the data for the use of BZ as measured
by LGE to predict cardiovascular risk appear prom-
ising, there are significant limitations in our under-
standing of this imaging finding. While histologic
data have confirmed that the peri-infarct zone is an
area of abnormal electrophysiologic properties [33],
it is not proven that this is what is being represent-
ed by the intermediate-intensity pixels near or with-
in a LGE identified infarct. Ideally, all of these pix-
els would be due to areas that are an admixture of
viable and non-viable myocardium, which may be
a substrate for arrhythmias. However, these pixels
may also occur due to other imaging conditions and
artifacts. Partial volume effects, where normal myo-
cardium, blood pool, or epicardial fat may exist
within the same voxel volume along with the myo-
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cardial infarct, can produce intermediate-intensity
values. This may produce the appearance of BZ on
LGE imaging, even if the actual tissue is not an ad-
mixture of viable and non-viable myocardium, and
presumably not arrhythmogenic [39]. Partial vol-
ume can occur in the short axis plane along the bor-
der of the infarct, as well as in the Z direction from
above or below the infarct. In addition, poor T1
nulling of normal myocardium, as well as low sig-
nal-to-noise ratios in general, can increase the
amount of intermediate-intensity pixels, and there-
by falsely elevate the BZ levels [40]. However, de-
spite all the potential confounders in the measure-
ment of BZ by LGE, these data as well as prior stud-
ies [14], suggest it has clear biologic implications. In
our data, BZ had a positive, but poor correlation with
both infarct size as well as infarct surface area, sug-
gesting that there is a minimal amount of artifact from
peri-infarct volume averaging. Techniques that may
minimize these other causes of intermediate-inten-
sity pixels should help further improve the specific-
ity of BZ to identify pro-arrhythmic substrate.
Contemporary literature on the use of LGE
imaging for the quantification of infarct BZ reveals
a number of statistical techniques for the measure-
ment and reporting of BZ burden. We analyzed our
images using these different techniques to look for
similarities and differences, as shown in Table 2.
One technique was reported in a recent study by
Yan et al. [14]; a cohort of 144 patients with CAD
had CMR images taken and were followed for an
average of 2.4 years. Yan et al. [14] defined BZ
(method II) as regions of signal intensity between
2 and 3 SD above normal myocardium, indexed to
infarct size (pixels with values 3 SD above). In this
cohort, BZ-II was a univariate predictor of total
mortality (p = 0.01) and cardiovascular mortality
(p = 0.009), as was LVEF (p = 0.01) and LV end-
systolic volume index (p = 0.002). A multivariable
model showed that BZ-II and LV end-systolic vol-
ume index were the 2 strongest, independent pre-
dictors of all-cause and cardiovascular mortality.
While these data demonstrate a link between BZ
and mortality, little is known about the selection or
actual cause of death for these patients, who exhib-
ited a higher than expected mortality rate of 20%
over 2.4 years. The mechanism for death was con-
jectured to be reentrant ventricular arrhythmias.
In the present study, we quantified BZ as re-
ported by Yan et al. [14], but also as a percent of
the total LV mass, in a similar fashion as infarct size
has been reported in the past. Reporting BZ as
a percentage of the infarct size [14] may discard im-
portant information about the gross amount of ar-
rhythmic BZ tissue. In both Yan’s report and in this
study, when BZ is indexed to infarct size (method
II) as opposed to LV mass (method I), there is an
inverse relationship between BZ % and infarct size,
as patients with smaller infarcts have larger BZ to
infarct size ratios. A patient with a relatively small
amount of arrhythmic BZ tissue, with a very small
infarct, would have a large reported BZ ratio by
method II. This inverse relationship of BZ and in-
farct size in method II does not correlate to the ob-
servation that larger infarcts are more arrhyt-
mogenic [11]. We felt that a more useful metric for
BZ would take into account the total amount of ar-
rhythmic substrate present, and should have a pos-
itive correlation with total infarct %. This lead to
method I, reporting BZ as indexed to total LV mass.
Another technique for BZ calculation has been
reported by Schmidt et al. [18]. This study examined
a cohort of 47 patients with CAD prior to ICD im-
plant for primary prevention of sudden death. These
patients underwent CMR, as well as either EPS or
non-invasive programmed stimulation to look for
ventricular inducibility. They defined BZ (method III)
as pixels greater than the peak value in the normal
myocardium but less than 50% of the highest signal
in scar tissue (visually defined). This was reported
unadjusted, in grams of myocardium. In this cohort,
BZ-III was a significant predictor of inducibility of
MVT (p = 0.015), but not total infarct size.
The comparison of techniques in this study
does not establish the superiority of one method
over another; rather, it highlights the variety of
reporting methods currently being employed for BZ
quantification, and that they differ significantly. All
3 methods described are similar in that they are
predictive of either mortality or EPS outcomes.
This is likely due to a common shared underlying
physiology that they indirectly or directly measure
— be it actual histologic BZ, or some relation to in-
farct mass or surface area. Until histologic confir-
mation of BZ is available and is related to a particu-
lar CMR technique, this issue will likely remain
ambiguous.
Limitations of the study
A significant limitation of this study is that it is
non-randomized and utilizes a small sample size.
With only 18 patients in the MVT group, the multi-
variate analysis can be of limited statistical accura-
cy, and should be considered only as thought pro-
voking and requiring additional study. However, the
univariate results should still be valid despite the
small sample and of significant importance. In ad-
dition, EPS inducibility identifies the presence of
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substrate for VT, but may not be an adequate sur-
rogate for arrhythmic sudden death. Finally, this
CMR dataset was acquired from 1998–2002, and the
image quality is somewhat less than with modern
techniques. However, this only underscores how
the different BZ algorithms respond diversely to
varying imaging artifacts in a clinical dataset.
Conclusions
This study provides additional information in
the understanding of the mechanism by which BZ
is associated with enhanced cardiovascular morta-
lity. Previously, inducible MVT during EPS has been
shown to be highly predictive of both sudden death
as well as total mortality [22, 41]. Our data provide
a confirmation of the link between BZ quantifica-
tion and arrhythmias in a human cohort. We also
demonstrated that BZ is not simply a surrogate
measurement of infarct size or infarct surface area
based on geometric relationships, but contains ad-
ditional data. Border zone is a more specific pre-
dictor of inducible arrhythmia than LVEF, so has
the potential for being an improved predictor of
mortality due to SCD. Although no such relation-
ship on outcome was identified in this study, this
may be related to the limited sample size. Further
studies are warranted, both to correlate imaging
findings of BZ to histology, and to assess the prog-
nostic significance of infarct characteristics such as
infarct size and BZ.
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